EU-HIP – Country visit report – Lithuania

This document has been developed within the remit of the project EU interoperability with HERA’s IT platform (EU-HIP). EU-HIP is a consortium of 15 European countries, coordinated by Statens Serum Institute (SSI), Denmark. The scope of the project is to support countries to enhance and improve national IT systems for health threats surveillance and management in an efficient and coordinated manner, with the objective of obtaining interoperability with the centralised IT platform of the EU Health Emergency Preparedness and Response Authority (HERA). HERA's IT platform (ATHINA - Advanced Technology for Health INtelligence and Action IT system) is currently under development and seeks to gather intelligence on health threats surveillance and medical countermeasures (MCMs) to support threat assessment and crisis management across Europe. The priority areas are pathogens with high pandemic potential (PHPP), antimicrobial resistance (AMR), and Chemical, Biological, Radiological & Nuclear (CBRN) threats, as well as appropriate medical countermeasures, such as medicinal products, medical devices and personal protective equipment (PPE). A baseline activity of the EU-HIP project is to perform a landscape assessment of countries’ IT systems, in relation to the above-mentioned priorities, across all countries involved in the consortium. In addition, in-depth country visits are being performed in a small group of countries to gain detailed insights into the functioning of such systems. This report presents the findings from the landscape assessment and in-depth country visit in Lithuania. Such exercise has also been performed in Croatia, Denmark and Iceland